Cancer treatment

Cancer treatment encompasses a wide array of therapeutic strategies aimed at controlling or eliminating cancerous cells within the body. These strategies include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgical interventions. Each treatment modality targets different aspects of cancer cell biology, such as cell division, DNA replication, or immune evasion. Research in cancer treatment focuses on improving the efficacy, specificity, and safety of these therapies to enhance patient outcomes and reduce side effects. At CymitQuimica, we provide a comprehensive range of compounds and reagents to support your research in developing innovative and effective cancer treatments.

20
- 50
- 100
- 200

products per page. 968 products on this category.

Product data	Purity	Price range	Estimated delivery
Lenvatinib Impurity 30 REF: 4Z-L-124036CAS: 17609-80-2 52671-64-4	- - -	To inquire	Wed 11 Dec 24
Folinic Acid Impurity 11 REF: 4Z-F-068025CAS: 6810-75-9	- - -	To inquire	Wed 11 Dec 24
Abiraterone Impurity 30 REF: 4Z-A-8280	- - -	To inquire	Wed 11 Dec 24
Enzalutamide Impurity 55 REF: 4Z-E-068068	- - -	To inquire	Wed 11 Dec 24
O-Desmethyl Lenvatinib REF: 4Z-L-124011CAS: 417717-04-5	- - -	To inquire	Wed 11 Dec 24
Lenvatinib Impurity 37 REF: 4Z-L-124043	- - -	To inquire	Wed 11 Dec 24
Fulvestrant Side Chain Impurity REF: 4Z-F-3113CAS: 148757-89-5	- - -	To inquire	Wed 11 Dec 24
Olaparib Impurity 18 (HOAT) REF: 4Z-O-032020CAS: 39968-33-7	- - -	To inquire	Wed 11 Dec 24
Folinic Acid Impurity 2 REF: 4Z-F-068011	- - -	To inquire	Wed 11 Dec 24
Carfilzomib Impurity 7 REF: 4Z-C-121010CAS: 2049025-76-3	- - -	To inquire	Wed 11 Dec 24
Olaparib Impurity 62 REF: 4Z-O-032067	- - -	To inquire	Wed 11 Dec 24
Carfilzomib Impurity 37 REF: 4Z-C-121040	- - -	To inquire	Wed 11 Dec 24
Nintedanib Impurity 93 REF: 4Z-N-066106	- - -	To inquire	Wed 11 Dec 24
Palbociclib Sulfamic Acid REF: 4Z-P-196007	- - -	To inquire	Wed 11 Dec 24
Abiraterone-N-β-D-Glucuronide REF: 4Z-A-8256CAS: 2307194-35-8	- - -	To inquire	Wed 11 Dec 24
Olaparib Impurity 11 REF: 4Z-O-032013	- - -	To inquire	Wed 11 Dec 24
Palbociclib Impurity 48 REF: 4Z-P-196055	- - -	To inquire	Wed 11 Dec 24
Palbociclib Dimer REF: 4Z-P-196100	- - -	To inquire	Wed 11 Dec 24
Olaparib Impurity 60 REF: 4Z-O-032065CAS: 218301-22-5	- - -	To inquire	Wed 11 Dec 24
Bisoctrizole REF: 4Z-B-119031	- - -	To inquire	Wed 11 Dec 24

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

Cancer treatment

Lenvatinib Impurity 30

Ref: 4Z-L-124036

Folinic Acid Impurity 11

Ref: 4Z-F-068025

Abiraterone Impurity 30

Ref: 4Z-A-8280

Enzalutamide Impurity 55

Ref: 4Z-E-068068

O-Desmethyl Lenvatinib

Ref: 4Z-L-124011

Lenvatinib Impurity 37

Ref: 4Z-L-124043

Fulvestrant Side Chain Impurity

Ref: 4Z-F-3113

Olaparib Impurity 18 (HOAT)

Ref: 4Z-O-032020

Folinic Acid Impurity 2

Ref: 4Z-F-068011

Carfilzomib Impurity 7

Ref: 4Z-C-121010

Olaparib Impurity 62

Ref: 4Z-O-032067

Carfilzomib Impurity 37

Ref: 4Z-C-121040

Nintedanib Impurity 93

Ref: 4Z-N-066106

Palbociclib Sulfamic Acid

Ref: 4Z-P-196007

Abiraterone-N-β-D-Glucuronide

Ref: 4Z-A-8256

Olaparib Impurity 11

Ref: 4Z-O-032013

Palbociclib Impurity 48

Ref: 4Z-P-196055

Palbociclib Dimer

Ref: 4Z-P-196100

Olaparib Impurity 60

Ref: 4Z-O-032065

Bisoctrizole

Ref: 4Z-B-119031